C-CAST: A New Paradigm in Global Drug Development – Navigating success in Japan
Listen to our expert talk about the latest market environment in Japan and how we can navigate you to a successful market entry.
- The market environment in Japan
- Key points and regulatory strategy for Japan market entry
- In-Country Clinical Caretaker (ICCC)
- Orphan Drug Designation (ODD)
- SAKIGAKE Designation
- Japan market entry strategies
Executive Vice President
CRO Business, CMIC Group
Learn more about our service/solutions here!
- In-Country Clinical Caretaker (ICCC) Services
- Japan Market Entry
- Consulting Services
- Clinical Trials